This research group is committed to driving transformative innovations in drug delivery systems to create a healthier, more sustainable future. Through the exploration of advanced oral and parenteral delivery technologies, the group aims to enhance the safety, efficacy, and accessibility of therapeutic treatments. Their work focuses on improving bioavailability, stability, and controlled release through the design of novel dosage forms, including controlled-release tablets, lipid-based nanoparticles, and bioprinted systems. By integrating green and resource-efficient formulation strategies with cutting-edge technologies, the group promotes responsible innovation that minimizes waste, optimizes therapeutic outcomes, and ensures patient-centered solutions. Through interdisciplinary collaboration and forward-thinking research, they strive to shape a more equitable and sustainable pharmaceutical landscape....More